Bringing the fundamentals into focus…
Back to Lumexa Imaging Holdings, Inc.
How Lumexa Imaging Holdings, Inc. stacks up
LMRI · against 466 other Healthcare companies of similar size
Valuation
42/ 100
Below the middle of the pack.
Ranked #271 of 467 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score44 peers with a valuation score of 40–49, including LMRI · Click a bar to see the companies
Why valuation scores 42?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield, but weaker earnings yield than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -2.6% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.9% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 67% of peers. Free cash flow yield: 2.9% vs peer median 0.0%
Metric by metric
Position: dot = LMRI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LMRI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 457 reported | -2.6% | 1.3% | 33% | 30% | |
| EBITDA yieldHigher is better · 472 reported | 3.9% | 4.2% | 49% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | 2.9% | -2.4% | 72% | 20% | |
| Book yieldHigher is better · 463 reported | 57.1% | 41.4% | 67% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around LMRIScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score